NIGHTINGALE HEALTH Ownership

7XE Stock  EUR 3.00  0.12  4.17%   
NIGHTINGALE HEALTH maintains a total of 39.09 Million outstanding shares. NIGHTINGALE HEALTH EO holds substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in NIGHTINGALE HEALTH EO. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

NIGHTINGALE Stock Ownership Analysis

About 50.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 0.25. NIGHTINGALE HEALTH had not issued any dividends in recent years. Nightingale Health Ltd. offers a health data platform that detects disease risks. The company was founded in 2002 and is based in Helsinki, Finland. NIGHTINGALE HEALTH is traded on Frankfurt Stock Exchange in Germany. For more info on NIGHTINGALE HEALTH EO please contact the company at 358 2073 01810 or go to http://nightingalehealth.com.

NIGHTINGALE HEALTH Outstanding Bonds

NIGHTINGALE HEALTH issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NIGHTINGALE HEALTH uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NIGHTINGALE bonds can be classified according to their maturity, which is the date when NIGHTINGALE HEALTH EO has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in NIGHTINGALE Stock

NIGHTINGALE HEALTH financial ratios help investors to determine whether NIGHTINGALE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NIGHTINGALE with respect to the benefits of owning NIGHTINGALE HEALTH security.